HSBC/CALL/AMGEN/400/0.1/17.01.25 | Market Closed - BOERSE MUENCHEN 03:35:17 2024-07-05 pm EDT | ||
| 0.39 EUR | +5.41% |
|
| Current month | -9.30% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 0.39 | +5.41% |
| 24-07-04 | 0.37 | -2.63% |
| 24-07-03 | 0.38 | -7.32% |
| 24-07-02 | 0.41 | -4.65% |
| 24-07-01 | 0.43 | 0.00% |
Real-time BOERSE MUENCHEN
Last update July 05, 2024 at 03:35 pm EDT
More quotesStatic data
| Product type | Warrant Plain-Vanilla |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | HSBC |
| WKN | HS75L7 |
| ISIN | DE000HS75L73 |
| Date issued | 2024-06-10 |
| Strike | 400 $ |
| Maturity | 2025-01-17 (194 Days) |
| Parity | 10 : 1 |
| Emission price | 0.5 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.62 € |
|---|---|
| Lowest since issue | 0.33 € |
| Spread | 0.02 € |
| Spread % | 4.88% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.9
USD
Average target price
316.4
USD
Spread / Average Target
+1.79%
- Stock Market
- Warrants
- Warrant
